Literature DB >> 16224248

Muscle-derived positive and negative regulators of the immune response.

Heinz Wiendl1, Reinhard Hohlfeld, Bernd C Kieseier.   

Abstract

PURPOSE OF REVIEW: Recent characterization of the expression and functioning of muscle-derived positive and negative regulators of the immune response will be highlighted in view of the concept that muscle cells can act as facultative antigen-presenting cells and should be considered as active participants rather than passive targets of immune reactions. RECENT
FINDINGS: Although lacking detectable major histocompatibility complex expression under physiologic conditions, under pathologic conditions muscle cells can express a variety of immunologically important molecules. Advances were made in characterizing the expression and functioning of classical and nonclassical major histocompatibility complex, adhesion, and costimulatory molecules. Muscle-related expression of the B7-family member called the inducible costimulatory signal ligand was identified as an important costimulatory signal for muscle immune interactions. In contrast, inducible expression of B7-H1 (PD-L1) and the nonclassical major histocompatibility complex molecule human leukocyte antigen-G were identified as relevant immune-inhibitory pathways.
SUMMARY: The recent identification of muscle-derived positive and negative signals has broad implications for understanding the active role of muscle in modulating muscle-immune interactions: these signals could modify the immune response against muscle fibers in cell-mediated injury in autoimmune muscle disorders or in various muscle infections. Furthermore, they could modulate the immune responses after protein-based or DNA-based vaccinations and influence muscle-directed antigen-specific and nonantigen-specific immune responses in either condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224248     DOI: 10.1097/01.bor.0000184164.69181.ca

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

1.  The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.

Authors:  Godwin Nchinda; Janelle Kuroiwa; Margarita Oks; Christine Trumpfheller; Chae Gyu Park; Yaoxing Huang; Drew Hannaman; Sarah J Schlesinger; Olga Mizenina; Michel C Nussenzweig; Klaus Uberla; Ralph M Steinman
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  [Adoptive T-cell therapy of rhabdomyosarcoma].

Authors:  K Simon-Keller; A Paschen; S Eichmüller; S Gattenlöhner; S Barth; E Koscielniak; I Leuschner; P Stöbel; A Hombach; H Abken; A Marx
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 3.  Sarcopenia - pathophysiology and clinical relevance.

Authors:  Michael Drey
Journal:  Wien Med Wochenschr       Date:  2011-07-29

Review 4.  Idiopathic inflammatory myopathies: current and future therapeutic options.

Authors:  Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 5.  Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.

Authors:  Ko-Jen Li; Cheng-Han Wu; Cheng-Hsun Lu; Chieh-Yu Shen; Yu-Min Kuo; Chang-Youh Tsai; Song-Chou Hsieh; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

6.  The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease.

Authors:  Heevy Al-Chaqmaqchi; Behnam Sadeghi; Manuchehr Abedi-Valugerdi; Sulaiman Al-Hashmi; Mona Fares; Raoul Kuiper; Joachim Lundahl; Moustapha Hassan; Ali Moshfegh
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.